Our Tesamorelin 13mg / Ipamorelin 3mg blend is designed for researchers investigating combined modulation of the growth hormone axis via both GHRH and ghrelin receptor pathways. By pairing a GHRH analogue with a selective ghrelin receptor agonist in fixed ratios, this vial supports structured exploration of additive or synergistic signalling effects.

Laboratory teams use this blend in studies comparing pulsatile versus sustained GH-related responses, receptor crosstalk, and downstream endocrine profiles relative to single-agent models. The defined composition simplifies protocol design where consistent proportions between the two peptides are critical.

As with all our GH and growth-factor research compounds, batch-specific testing documentation is available on request to support rigorous, publication-ready work.

Disclaimer: Supplied for research purposes only. Not for human or animal use or consumption.